No abstract available
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
-
Comment
MeSH terms
-
Antineoplastic Agents, Immunological* / adverse effects
-
Humans
-
Ipilimumab / therapeutic use
-
Melanoma* / drug therapy
-
Melanoma* / genetics
-
Nivolumab / therapeutic use
Substances
-
Antineoplastic Agents, Immunological
-
Ipilimumab
-
Nivolumab